Market Overview:
The global real-world evidence solutions market is expected to grow at a CAGR of 16.5% during the forecast period from 2018 to 2030. The market growth can be attributed to the increasing demand for real-world evidence solutions from pharmaceutical and medical device companies, healthcare payers, and healthcare providers. The clinical setting data segment is expected to hold the largest share of the global real-world evidence solutions market in 2018. However, the pharmacy data segment is projected to grow at the highest CAGR during the forecast period.
Product Definition:
Real World Evidence Solutions is the gathering and analysis of data from actual clinical practice, as opposed to data from clinical trials. The use of real-world evidence can help to improve the understanding of how a drug or treatment works in the "real world" and can help to inform decisions about which treatments are most effective for patients.
Clinical Setting Data:
The global clinical setting data market size was valued at USD 1.8 billion in 2016 and is expected to grow at a CAGR of XX% over the forecast period. The growth can be attributed to factors such as increasing demand for personalized healthcare, rising geriatric population, and growing number of chronic diseases requiring long-term care.
Clinical setting data (CSD) is patient-related information that helps healthcare professionals make decisions regarding treatment options.
Claims Data:
The global what is claims data and it's usage in real world evidence solutions market size was valued at USD 6.5 billion in 2018 and is expected to grow at a compound annual growth rate (CAGR) of 14.4% from 2019 to 2025.
Application Insights:
The pharmaceutical and medical device companies application segment accounted for the largest revenue share in 2017. The segment is expected to grow at a significant rate over the forecast period. This growth can be attributed to an increase in demand for devices that require clinical data from real world settings. For instance, cardiovascular diseases need high accuracy of diagnostics so as to provide better treatment options, which is driving this market demandingly.
The healthcare payers application segment was valued over USD 200 million in 2017 owing to its growing acceptance across various payer types such as government-sponsored programs and private health insurers. Increasing awareness about cost reduction techniques among them is expected to drive their adoption further contributing towards revenue growth during the forecast period 2030 globally.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period owing to high awareness levels regarding real world evidence solutions, growing adoption by healthcare providers and payers, and increasing investments by companies for data analytics. Moreover, a rise in chronic diseases burden coupled with rising demand for pharmaceuticals has also contributed to regional growth.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to factors such as rapidly improving healthcare infrastructure and economic development that leads towards improvement in living standards of people resulting into an increase in demand for medicines which ultimately boosts market growth. Furthermore, government initiatives encouraging R&D activities are also expected drive regional expansion over the next eight years (2018-2030).
Growth Factors:
- Increasing demand for Real World Evidence Solutions from the pharmaceutical and biotechnology industries to support their product development and marketing efforts.
- The increasing number of clinical trials being conducted globally is expected to drive the demand for Real World Evidence Solutions over the next few years.
- Growing focus on reducing healthcare costs is also expected to fuel the demand for Real World Evidence Solutions in the near future.
- Rising awareness about the benefits of using real-world data in decision-making is likely to boost market growth during the forecast period.
Scope Of The Report
Report Attributes
Report Details
Report Title
Real World Evidence Solutions Market Research Report
By Type
Clinical Setting Data, Claims Data, Pharmacy Data, Patient Powered Data
By Application
Pharmaceutical and Medical Device Companies, Healthcare Payers, Healthcare Providers, Others
By Companies
Iqvia, IBM, Pharmaceutical Product Development, Parexel, United Health Group, Perkinelmer, Icon, Oracle, Cognizant, Syneos Health, Anthem, Clinigen, SAS Institute
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
150
Number of Tables & Figures
105
Customization Available
Yes, the report can be customized as per your need.
Global Real World Evidence Solutions Market Report Segments:
The global Real World Evidence Solutions market is segmented on the basis of:
Types
Clinical Setting Data, Claims Data, Pharmacy Data, Patient Powered Data
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Pharmaceutical and Medical Device Companies, Healthcare Payers, Healthcare Providers, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Iqvia
- IBM
- Pharmaceutical Product Development
- Parexel
- United Health Group
- Perkinelmer
- Icon
- Oracle
- Cognizant
- Syneos Health
- Anthem
- Clinigen
- SAS Institute
Highlights of The Real World Evidence Solutions Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Clinical Setting Data
- Claims Data
- Pharmacy Data
- Patient Powered Data
- By Application:
- Pharmaceutical and Medical Device Companies
- Healthcare Payers
- Healthcare Providers
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Real World Evidence Solutions Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Real World Evidence Solutions is a company that provides evidence-based solutions to public policy and social issues. They offer consulting, research, and training services to help organizations make informed decisions about their policies and programs.
Some of the major players in the real world evidence solutions market are Iqvia, IBM, Pharmaceutical Product Development, Parexel, United Health Group, Perkinelmer, Icon, Oracle, Cognizant, Syneos Health, Anthem, Clinigen, SAS Institute.
The real world evidence solutions market is expected to register a CAGR of 16.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Real World Evidence Solutions Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Real World Evidence Solutions Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Real World Evidence Solutions Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Real World Evidence Solutions Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Real World Evidence Solutions Market Size & Forecast, 2018-2028
4.5.1 Real World Evidence Solutions Market Size and Y-o-Y Growth
4.5.2 Real World Evidence Solutions Market Absolute $ Opportunity
Chapter 5 Global Real World Evidence Solutions Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Real World Evidence Solutions Market Size Forecast by Type
5.2.1 Clinical Setting Data
5.2.2 Claims Data
5.2.3 Pharmacy Data
5.2.4 Patient Powered Data
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Real World Evidence Solutions Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Real World Evidence Solutions Market Size Forecast by Applications
6.2.1 Pharmaceutical and Medical Device Companies
6.2.2 Healthcare Payers
6.2.3 Healthcare Providers
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Real World Evidence Solutions Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Real World Evidence Solutions Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Real World Evidence Solutions Analysis and Forecast
9.1 Introduction
9.2 North America Real World Evidence Solutions Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Real World Evidence Solutions Market Size Forecast by Type
9.6.1 Clinical Setting Data
9.6.2 Claims Data
9.6.3 Pharmacy Data
9.6.4 Patient Powered Data
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Real World Evidence Solutions Market Size Forecast by Applications
9.10.1 Pharmaceutical and Medical Device Companies
9.10.2 Healthcare Payers
9.10.3 Healthcare Providers
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Real World Evidence Solutions Analysis and Forecast
10.1 Introduction
10.2 Europe Real World Evidence Solutions Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Real World Evidence Solutions Market Size Forecast by Type
10.6.1 Clinical Setting Data
10.6.2 Claims Data
10.6.3 Pharmacy Data
10.6.4 Patient Powered Data
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Real World Evidence Solutions Market Size Forecast by Applications
10.10.1 Pharmaceutical and Medical Device Companies
10.10.2 Healthcare Payers
10.10.3 Healthcare Providers
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Real World Evidence Solutions Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Real World Evidence Solutions Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Real World Evidence Solutions Market Size Forecast by Type
11.6.1 Clinical Setting Data
11.6.2 Claims Data
11.6.3 Pharmacy Data
11.6.4 Patient Powered Data
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Real World Evidence Solutions Market Size Forecast by Applications
11.10.1 Pharmaceutical and Medical Device Companies
11.10.2 Healthcare Payers
11.10.3 Healthcare Providers
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Real World Evidence Solutions Analysis and Forecast
12.1 Introduction
12.2 Latin America Real World Evidence Solutions Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Real World Evidence Solutions Market Size Forecast by Type
12.6.1 Clinical Setting Data
12.6.2 Claims Data
12.6.3 Pharmacy Data
12.6.4 Patient Powered Data
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Real World Evidence Solutions Market Size Forecast by Applications
12.10.1 Pharmaceutical and Medical Device Companies
12.10.2 Healthcare Payers
12.10.3 Healthcare Providers
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Real World Evidence Solutions Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Real World Evidence Solutions Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Real World Evidence Solutions Market Size Forecast by Type
13.6.1 Clinical Setting Data
13.6.2 Claims Data
13.6.3 Pharmacy Data
13.6.4 Patient Powered Data
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Real World Evidence Solutions Market Size Forecast by Applications
13.10.1 Pharmaceutical and Medical Device Companies
13.10.2 Healthcare Payers
13.10.3 Healthcare Providers
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Real World Evidence Solutions Market: Competitive Dashboard
14.2 Global Real World Evidence Solutions Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Iqvia
14.3.2 IBM
14.3.3 Pharmaceutical Product Development
14.3.4 Parexel
14.3.5 United Health Group
14.3.6 Perkinelmer
14.3.7 Icon
14.3.8 Oracle
14.3.9 Cognizant
14.3.10 Syneos Health
14.3.11 Anthem
14.3.12 Clinigen
14.3.13 SAS Institute
